Results 151 to 160 of about 30,314 (207)

Retraction of: Material and regenerative properties of an osteon-mimetic cortical bone-like scaffold. [PDF]

Regen Biomater
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dissociation of α2-plasmin-inhibitor-plasmin complex and regeneration of plasmin activity by SDS treatment

Thrombosis Research, 1993
In order to understand the mechanism for the complex between alpha 2-plasmin-inhibitor (alpha 2-PI) and plasmin to express its specific activity on fibrin autography after SDS-PAGE, we analyzed the effects of SDS on alpha 2-PI molecule and alpha 2-PI-plasmin complex.
D, Yan, T, Urano, Y, Takada, A, Takada
openaire   +2 more sources

Plasmin-α2-plasmin inhibitor complex and α2-plasmin inhibitor in chronic subdural hematoma

Journal of Neurosurgery, 1989
✓ Levels of the plasmin-α2-plasmin inhibitor complex (PLN-A2PI complex) and α2-plasmin inhibitor (A2PI) were determined by enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies in 59 patients with 66 chronic subdural hematomas (SDH's). Normal concentrations of the PLN-A2PI complex and A2PI in plasma are below 0.8 µg/ml and 60.5 ± 16.1 µg/
K, Saito, H, Ito, T, Hasegawa, S, Yamamoto   +3 more
openaire   +2 more sources

Fibrinogenolysis by insolubilized plasmin

Clinica Chimica Acta, 1974
Abstract Insolubilized plasmin was prepared by chemical fixation of the enzyme to CNBr-activated agarose. The enzyme is still active, whereas its specific activity is reduced. Fibrinogenolysis by insolubilized plasmin is compared to fibrinogenolysis by the soluble form of the enzyme.
F R, Matthias, W, Krause, D L, Heene
openaire   +2 more sources

Plasmin-α2-antiplasmin complexes (plasmin—plasmin inhibitor complexes)

1999
α2-Antiplasmin (new name: plasmin inhibitor) is the most important plasmin inhibitor. Its rapid reaction with plasmin results in the formation of an inactive complex composed of one molecule of each component. Two steps are involved in this process: first a reversible complex is formed between the lysine-binding sites of plasmin and complementary sites
E. Hattey, M. Haumer, M. R. Griffiths, V. Carroll, B. R. Binder   +4 more
openaire   +1 more source

EXPERIENCE WITH PLASMIN INHIBITORS

Acta Ophthalmologica, 1992
Abstract The involvement and role of the plasmino‐gen activator‐plasmin system in normal and pathological wound healing is reviewed. The methods currently available for demonstrating plasmin activity are briefly described. The article also reviews some other serine proteases potentially involved in pathological wound healing processes.
T, Tervo, G B, van Setten, K, Tervo, A, Tarkkanen   +3 more
openaire   +2 more sources

A Standard for Human Plasmin

Thrombosis and Haemostasis, 1975
SummaryAn international collaborative study involving ten laboratories was undertaken to assess the suitability of a preparation of human plasmin in 50% glycerol to serve as a single standard for the bioassay of plasmin activity. The study included examination of the stability of the proposed standard and comparisons between assay methods.
T B, Kirkwood, P J, Campbell, P J, Gaffney   +2 more
openaire   +2 more sources

Plasmin in subretinal fluid

Acta Ophthalmologica, 1988
Abstract. Proteolytic activity was studied in subretinal fluid from 56 eyes with rhegmatogenous retinal detachment without vitreous or subretinal hemorrhage. Active plasmin (1.0–15.2 μg/ml) was found in 33 eyes and plasmin‐inhibitor complexes in 3 eyes.
I J, Immonen, E M, Salonen, A I, Vaheri, L T, Laatikainen   +3 more
openaire   +2 more sources

Fragmentation of Haptoglobin by Plasmin

Canadian Journal of Biochemistry, 1971
Human haptoglobin type Hp 1-1, is hydrolyzed by plasmin to give two dissimilar products, P1 and P2, with molecular weights of 78 000 and 17 000, respectively. The larger fragment, P1 has the same N-terminal amino acids, valine and isoleucine, as intact haptoglobin.
F, Ofosu, D W, Campbell, G E, Connell
openaire   +2 more sources